Have a personal or library account? Click to login
Prevalence and Prognostic Impact of Hypernatremia in Sepsis and Septic Shock Patients in The Intensive Care Unit: A Single Centre Experience Cover

Prevalence and Prognostic Impact of Hypernatremia in Sepsis and Septic Shock Patients in The Intensive Care Unit: A Single Centre Experience

Open Access
|Jan 2020

References

  1. Mohan A, Shrestha P, Guleria R, et al. Development of a mortality prediction formula due to sepsis/ severe sepsis in a medical intensive care unit. Lung India; 2015; 2015 Jul-Aug;32(4):313-9
  2. Andre S.F, Susana M.V, Uzay K, et al. Mortality prediction of septic shock patients using probabilistic fuzzy systems. Applied Soft Computing. 2016 May (42); 194-203.
  3. Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA 2017 Oct 3;318(13):1241-1249.
  4. Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: research priorities for sepsis and septic shock. Crit Care Med. 2018 Aug;46(8):1334-1356.
  5. Micek ST, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006 Nov;34(11):2707-13.
  6. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). 2016 Feb 23;315(8):801-10.
  7. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):775-87
  8. Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2015 Jan;43(1):3-12
  9. Damiani E, Donati A, Serafini G, et al. Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies. PLoS One. 2015 May 6;10(5):e0125827
  10. Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: Results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015 Sep;41(9):1620-8
  11. Seymour CW, Gesten F, Prescot H, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017 Jun 8;376(23):2235-2244
  12. Liu VX, Morehouse JW, Marelich GP, et al. Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values. Am J Respir Crit Care Med. 2016 Jun 1;193(11):1264-70.
  13. Leisman DE, Doerfler ME, Ward MF, et al.: Survival benefit and cost savings from compliance with a simplified 3-hour sepsis bundle in a series of prospective, multisite, observational cohorts. Crit Care Med. 2017 Mar;45(3):395-406
  14. Ferrer R, Martin-Loeches I, Phillips G, et al.: Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program. Crit Care Med. 2014 Aug;42(8):1749-55
  15. Kumar A. Systematic bias in meta-analyses of time to antimicrobial in sepsis studies. Crit Care Med. 2016 Apr;44(4):e234-5.
  16. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017 Mar;45(3):486-552.
  17. Ni-HB, Hu XX, Huang XF et al. Risk Factors and Outcomes in Patients with Hypernatremia and Sepsis. Am J Med Sci. 2016 Jun;351(6):601-5.
  18. Charles PE, Gibot S. Predicting outcome in patients with sepsis: new biomarkers for old expectations. Critical Care. 2014 Feb 12;18(1):108.
  19. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006 Jun;34(6):1589-96.
  20. Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press. 2010 Dec;8(2):72-81
  21. Muhsin SA, Mount DB. Diagnosis and treatment of hypernatremia. Best Pract Res Clin Endocrinol Metab. 2016 Mar;30 (2):189-203.
  22. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000 May 18;342(20):1493-9
  23. O’Donoghue SD, Dulhunty JM, Bandeshe HK, et al. Acquired hypernatraemia is an independent predictor of mortality in critically ill patients. Anaesthesia. 2009 May;64(5):514-20.
  24. Darmon M, Timsit JF, Francais A, et al. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant. 2010 Aug;25(8):2510-5.
  25. Hoorn EJ, Betjes MG, Weigel J, et al. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant. 2008 May;23(5):1562-8
  26. Lindner G, Kneidinger N, Holzinger U, et al. Tonicity balance in patients with hypernatremia acquired in the intensive care unit. Am J Kidney Dis. 2009 Oct;54(4):674-9.
  27. Polderman KH, Schreuder WO, Strack van Schijndel RJ, et al. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999 Jun;27(6):1105-8.
  28. Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007 Dec;50(6):952-7.
  29. Lindner G, Funk GC, Lassnigg A, et al. Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality. Intensive Care Med. 2010 Oct;36(10):1718-23.
  30. Waite MD, Fuhrman SA, Badawi O, et al. Intensive care unit–acquired hypernatremia is an independent predictor of increased mortality and length of stay. J Crit Care. 2013 Aug;28(4):405-12.
  31. Van De Louw A, Shafer C, Schaefer E. Early intensive care unit-acquired hypernatremia in severe sepsis patients receiving 0.9% saline fluid resuscitation. Acta Anaesthesiol Scand. 2014 Sep; 58(8):1007-14.
  32. Bodonyi-Kovacs G, Lecker SH. Electrolyte-free water clearance: a key to the diagnosis of hypernatremia in resolving acute renal failure. Clin Exp Nephrol. 2008 Feb;12(1):74-8.
  33. Lindner G, Schwarz C, Funk GC. Osmotic diuresis due to urea as the cause of hypernatraemia in critically ill patients. Nephrol Dial Transplant. 2012 Mar;27(3):962-7.
  34. Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010 Mar;65(3):283-93.
  35. Lindner G, Kneidinger N, Holzinger U, et al. Tonicity balance in patients with hypernatremia acquired in the intensive care unit. Am J Kidney Dis. 2009 Oct;54(4):674-9.
  36. Pazmino PA, Pazmino BP. Treatment of acute hypernatremia with hemodialysis. Am J Nephrol. 1993; 13(4):260-5.
  37. Park HS, Hong YA, Kim HG, et al. Usefulness of continuous renal replacement therapy for correcting hypernatremia in a patient with severe congestive heart failure. Hemodial Int. 2012 Oct;16(4):559-63
DOI: https://doi.org/10.2478/jccm-2020-0001 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 52 - 58
Submitted on: Oct 19, 2019
Accepted on: Jan 12, 2020
Published on: Jan 31, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Mohamed Shirazy, Islam Omar, Duaa Abduljabbar, Kamel Bousselmi, Maryam Alkhaja, Anis Chaari, Vipin Kauts, Karim Hakim, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.